2,145
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Microchannel-embedded implantable device with fibrosis suppression for prolonged controlled drug delivery

, , , , , , , & show all
Pages 489-498 | Received 10 Nov 2021, Accepted 17 Jan 2022, Published online: 11 Feb 2022

References

  • Araújo J, Gonzalez E, Egea MA, et al. (2009). Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine 5:394–401.
  • Asrory VDO, Sitompul R, Artini W, et al. (2020). The inflammatory and foreign body reaction of polymethyl methacrylate glaucoma drainage device in the rabbit eye. Transl Vis Sci Technol 9:20.
  • Bank RA. (2019). Limiting biomaterial fibrosis. Nat Mater 18:781.
  • Carnicer-Lombarte A, Chen ST, Malliaras GG, et al. (2012). Foreign body reaction to implanted biomaterials and its impact in nerve neuroprosthetics. Front Bioeng 9:622524.
  • Choi JS, Huh BK, Lee SJ, et al. (2020). Tranilast-loaded tubular scaffold and surgical suture for suppression of stenosis after tracheal prosthesis transplantation. J Ind Eng Chem 82:81–8.
  • Chun NY, Kim SN, Choi YS, et al. (2020). PCN-223 as a drug carrier for potential treatment of colorectal cancer. J Ind Eng Chem 84:290–6.
  • Cirri M, Maestrelli F, Corti G, et al. (2007). Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants. Drug Deliv 14:247–55.
  • Diegelmann RF, Evans MC. (2004). Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9:283–9.
  • Elman NM, Duc HLH, Cima MJ. (2009). An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care. Biomed Microdevices 11:625–31.
  • Farra R, Sheppard NF, McCabe L, et al. (2012). First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med 4:122ra21.
  • Gardner P. (2006). Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities. Expert Opin Drug Deliv 3:479–87.
  • Gautam R, Singh RD, Sharma VP, et al. (2012). Biocompatibility of polymethylmethacrylate resins used in dentistry. J Biomed Mater Res B Appl Biomater 100:1444–50.
  • Hameed HA, Khan S, Shahid M, et al. (2020). Engineering of naproxen loaded polymer hybrid enteric microspheres for modified release tablets: development, characterization, in silico modelling and in vivo evaluation. Drug Des Devel Ther 14:27–41.
  • Heo MY, Piao ZZ, Kim TW, et al. (2005). Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Arch Pharm Res 28:604–11.
  • Hilt JZ, Peppas NA. (2005). Microfabricated drug delivery devices. Int J Pharm 306:15–23.
  • Holmes D, Fitzgerald P, Goldberg S, et al. (2000). The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial. Am Heart J 139:23–31.
  • Jeong H, Rho J, Shin JY, et al. (2018). Mechanical properties and cytotoxicity of PLA/PCL films. Biomed Eng Lett 8:267–72.
  • Ji HB, Kim SN, Lee SH, et al. (2020). Soft implantable device with drug-diffusion channels for the controlled release of diclofenac. J Control Release 318:176–84.
  • Kim BH, Huh BK, Lee WS, et al. (2019). Silicone implant coated with tranilast-loaded polymer in a pattern for fibrosis suppression. Polymers 11:223.
  • Kincl M, Vrečer F, Veber M. (2004). Characterization of factors affecting the release of low-solubility drug from prolonged release tablets. Anal Chim Acta 502:107–13.
  • Lee KJ, Yang SY, Ryu W. (2012). Controlled release of bupivacaine HCl through microchannels of biodegradable drug delivery device. Biomed Microdevices 14:583–93.
  • Lee SH, Kim BH, Park CG, et al. (2018). Implantable small device enabled with magnetic actuation for on-demand and pulsatile drug delivery. J Control Release 286:224–30.
  • Lee SH, Park M, Park CG, et al. (2012). Microchip for sustained drug delivery by diffusion through microchannels. AAPS PharmSciTech 13:211–7.
  • Lee SH, Park M, Park CG, et al. (2014). Implantable micro-chip for controlled delivery of diclofenac sodium. J Control Release 196:52–9.
  • Marcus J, Alyssa P, Stephanie B, et al. (2016). Investigation of diffusion characteristics through microfluidic channels for passive drug delivery applications. J Drug Deliv 2016:7913616.
  • Martin C, De Baerdemaeker A, Poelaert J, et al. (2016). Controlled-release of opioids for improved pain management. Mater Today 19:491–502.
  • Martin S, Macarena S, Charlotte S, et al. (2012). Biocompatibility and antifibrotic effect of UV-cross-linked hyaluronate as a release-system for tranilast after trabeculectomy in a rabbit model – a pilot study. Curr Eye Res 37:463–70.
  • Meng E, Hoang T. (2012). Micro- and nano-fabricated implantable drug-delivery systems. Ther Deliv 3:1457–67.
  • Meng X, Nikolic-Paterson DJ, Lan HY. (2016). TGF-β: the master regulator of fibrosis. Nat Rev Nephrol 12:325–38.
  • Nam SY, Ji HB, Shin BH, et al. (2021). Silicone breast implant coated with triamcinolone inhibited breast-implant-induced fibrosis in a porcine model. Materials 14:3917.
  • Odom DM, Mladsi DM, Saag KG, et al. (2014). Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews. Clin Ther 36:906–17.
  • Park S, Park M, Kim BH, et al. (2015). Acute suppression of TGF-β with local, sustained release of tranilast against the formation of fibrous capsules around silicone implants. J Control Release 200:125–37.
  • Paz E, Ballesteros Y, Abenojar J, et al. (2021). Advanced G-MPS-PMMA bone cements: influence of graphene silanisation on fatigue performance, thermal properties and biocompatibility. Nanomaterials 11:139.
  • Pons-Faudoa FP, Ballerini A, Sakamoto J, et al. (2019). Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases. Biomed Microdevices 21:1–22.
  • Robotti F, Sterner I, Bottan S, et al. (2020). Microengineered biosynthesized cellulose as anti-fibrotic in vivo protection for cardiac implantable electronic devices. Biomaterials 229:119583.
  • Sanjay ST, Zhou W, Dou M, et al. (2018). Recent advances of controlled drug delivery using microfluidic platforms. Adv Drug Deliv Rev 128:3–28.
  • Singh M, Gersh BJ, McClelland RL, et al. (2004). Clinical and angiographic predictors of restenosis after percutaneous coronary intervention. Circulation 109:2727–31.
  • Stevenson CL, Santini JT, Jr, Langer R. (2012). Reservoir-based drug delivery systems utilizing microtechnology. Adv Drug Deliv Rev 64:1590–602.
  • Sutradhar KB, Sumi CD. (2016). Implantable microchip: the futuristic controlled drug delivery system. Drug Deliv 23:1–11.
  • Ward WK. (2008). A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol 2:768–77.
  • Yang D, Lee JS, Choi CK, et al. (2018a). Microchannel system for rate-controlled, sequential, and pH-responsive drug delivery. Acta Biomater 68:249–60.
  • Yang W, Sabi-Mouka EMB, Wang L, et al. (2018b). Determination of tranilast in bio-samples by LC–MS/MS: application to a pharmacokinetic and brain tissue distribution study in rats. J Pharm Biomed Anal 147:479–84.